ResultsIQ › Latest results › Manipal Health Enterprises Limited
Manipal Health Enterprises Limited Q1 FY27 earnings call summary
NSE: MANIPALHOS · BSE: 544847
Earnings call of 21 Aug 2026, summarised by AI from the filing.
Manipal Health Q1 FY27 revenue ₹3,091 cr, up over 38% YoY, with capex of ₹2,000 cr planned for the year.
Key takeaways
- Q1 revenue ₹3,091 cr, growth of over 38% year-on-year, driven by volumes.
- Capex guidance ₹2,000 cr capex in current year; ₹4,000 cr over next 3-4 years for 3,000 beds.
- Growth drivers Volume-led growth, CONGO-R mix, greenfield ramp-up, Sahyadri integration, and deleveraging.
- Margin pressure Ex-Sahyadri margin dipped to 25% from 26.5% on greenfield doctor costs and slow scheme collections.
Manipal Health Enterprises Limited Q1 FY27 results
As filed: Revenue ₹3,091 cr, EBITDA ₹737 cr, PAT ₹243 cr, EBITDA margin 23.8%.
Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹3,091 cr). Scored once a year-earlier consolidated quarter exists.
Manipal Health Enterprises Limited earnings call, investor presentation and press release summaries
Figures from the company's filings with NSE and BSE. Not investment advice.